Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine.
Saved in:
| Title: | Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine. |
|---|---|
| Authors: | Kontandreopoulou, Christina-Nefeli1 (AUTHOR), Diamantopoulos, Panagiotis T.1 (AUTHOR), Giannopoulos, Andreas2 (AUTHOR), Symeonidis, Argiris3 (AUTHOR), Kotsianidis, Ioannis4 (AUTHOR), Pappa, Vasiliki5 (AUTHOR), Galanopoulos, Athanasios6 (AUTHOR), Panayiotidis, Panayiotis7 (AUTHOR), Dimou, Maria7 (AUTHOR), Solomou, Elena3 (AUTHOR), Loupis, Theodoros2 (AUTHOR), Zoi, Katerina2 (AUTHOR), Giannakopoulou, Nefeli1 (AUTHOR), Dryllis, Georgios1 (AUTHOR), Hatzidavid, Sevastianos1 (AUTHOR), Viniou, Nora-Athina1 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Mar2022, Vol. 63 Issue 3, p729-737. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
